TWST CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Twist Bioscience Corporation Shareholders of Securities Fraud Class Action LawsuitNewsfile Corp • 01/26/23
Twist Bioscience Begins Shipping Commercial Product from Synthetic DNA Manufacturing Factory of the FutureBusiness Wire • 01/26/23
TWIST BIOSCIENCE CORPORATION (TWST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of The Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against Twist Bioscience Corporation (TWST)Newsfile Corp • 01/26/23
FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Twist Bioscience Corporation with Losses of $100,000 to Contact the FirmAccesswire • 01/26/23
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Twist Bioscience (TWST) Investors with Losses to Contact Firm's Attorneys, Securities Class Action PendingNewsfile Corp • 01/26/23
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Twist Bioscience Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TWSTPRNewsWire • 01/23/23
TWIST BIOSCIENCE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Twist Bioscience Corporation - TWSTPRNewsWire • 01/21/23
TWST NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWSTNewsfile Corp • 01/21/23
Kessler Topaz Meltzer & Check, LLP Announces it Has Filed a Securities Fraud Class Action Lawsuit against Twist Bioscience CorporationNewsfile Corp • 01/20/23
HAGENS BERMAN Alerts Twist Bioscience (TWST) Investors to Approaching Deadline in Securities Fraud Class Action, Encourages Investors with Losses to Contact Firm's AttorneysNewsfile Corp • 01/19/23
Twist Bioscience to Report Fiscal 2023 First Quarter Financial Results on Friday, February 3, 2023Business Wire • 01/19/23
ROSEN, Top Ranked Investor Counsel, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWSTNewsfile Corp • 01/17/23
Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Twist Bioscience Corporation Investors of Securities Fraud Class Action LawsuitNewsfile Corp • 01/16/23
TOP RANKED ROSEN LAW FIRM Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWSTPRNewsWire • 01/15/23
CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Has Filed a Securities Fraud Class Action Lawsuit against Twist Bioscience CorporationNewsfile Corp • 01/14/23
CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Has Filed A Securities Fraud Class Action Lawsuit Against Twist Bioscience CorporationPRNewsWire • 01/13/23
TWST NOTICE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWSTNewsfile Corp • 01/13/23
Twist Bioscience Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More InformationNewsfile Corp • 01/12/23
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Twist Bioscience (TWST) Investors with Losses to Contact Firm's Attorneys, Deadline Approaching in Securities Fraud Class ActionNewsfile Corp • 01/11/23
Twist Class Action: Levi & Korsinsky Reminds Twist Bioscience Corporation Investors Of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of February 10, 2023 - TWSTNewsfile Corp • 01/11/23
Kessler Topaz Meltzer & Check, LLP Has Filed a Securities Fraud Class Action Lawsuit Against Twist Bioscience CorporationNewsfile Corp • 01/11/23
Twist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease and Hereditary Cancer Research and Support DiagnosticsBusiness Wire • 01/10/23
Twist Bioscience and Astellas Enter into Multitarget Antibody Discovery Research CollaborationBusiness Wire • 01/09/23
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Twist Bioscience Corporation - TWSTNewsfile Corp • 01/07/23
TWST NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Twist Bioscience Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - TWSTNewsfile Corp • 01/07/23
